ZA93694B - Pharmaceutical treatments. - Google Patents

Pharmaceutical treatments.

Info

Publication number
ZA93694B
ZA93694B ZA93694A ZA93694A ZA93694B ZA 93694 B ZA93694 B ZA 93694B ZA 93694 A ZA93694 A ZA 93694A ZA 93694 A ZA93694 A ZA 93694A ZA 93694 B ZA93694 B ZA 93694B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical treatments
treatments
pharmaceutical
Prior art date
Application number
ZA93694A
Inventor
Kristine Hagen Johnson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to ZA93694A priority Critical patent/ZA93694B/en
Publication of ZA93694B publication Critical patent/ZA93694B/en

Links

ZA93694A 1993-02-01 1993-02-01 Pharmaceutical treatments. ZA93694B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA93694A ZA93694B (en) 1993-02-01 1993-02-01 Pharmaceutical treatments.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA93694A ZA93694B (en) 1993-02-01 1993-02-01 Pharmaceutical treatments.

Publications (1)

Publication Number Publication Date
ZA93694B true ZA93694B (en) 1993-06-03

Family

ID=25582532

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93694A ZA93694B (en) 1993-02-01 1993-02-01 Pharmaceutical treatments.

Country Status (1)

Country Link
ZA (1) ZA93694B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012485A1 (en) * 1994-10-20 1996-05-02 Eli Lilly And Company Treatment of disorders with duloxetine
EP0693282A3 (en) * 1994-07-18 1996-12-18 Lilly Co Eli Duloxetine enteric pellets
EP0919236A1 (en) * 1997-09-23 1999-06-02 Eli Lilly And Company Use of a norepinephrine uptake inhibitor for the treatment of oppositional defiant disorder
EP0919235A1 (en) * 1997-09-23 1999-06-02 Eli Lilly And Company Use of a norepinephrine reuptake inhibitor for the treatment of conduct disorder
WO2001017521A1 (en) * 1999-09-03 2001-03-15 Eli Lilly And Company Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
CN103130660A (en) * 2011-11-25 2013-06-05 厦门福满药业有限公司 Acidic salt and crystal of dapoxetine and preparation method of crystal

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693282A3 (en) * 1994-07-18 1996-12-18 Lilly Co Eli Duloxetine enteric pellets
WO1996012485A1 (en) * 1994-10-20 1996-05-02 Eli Lilly And Company Treatment of disorders with duloxetine
EP0919236A1 (en) * 1997-09-23 1999-06-02 Eli Lilly And Company Use of a norepinephrine uptake inhibitor for the treatment of oppositional defiant disorder
EP0919235A1 (en) * 1997-09-23 1999-06-02 Eli Lilly And Company Use of a norepinephrine reuptake inhibitor for the treatment of conduct disorder
WO2001017521A1 (en) * 1999-09-03 2001-03-15 Eli Lilly And Company Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
EP1671628A1 (en) * 1999-09-03 2006-06-21 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
US7718705B1 (en) 1999-09-03 2010-05-18 Eli Lilly And Company Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
EP1889614A3 (en) * 1999-09-03 2010-09-22 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
CN103130660A (en) * 2011-11-25 2013-06-05 厦门福满药业有限公司 Acidic salt and crystal of dapoxetine and preparation method of crystal

Similar Documents

Publication Publication Date Title
EP0655440A3 (en) 1-Aminoethylindoles.
EP0655256A3 (en) Inhaler.
EP0642367A4 (en) Electrotherapy device.
GR3025363T3 (en) Medicaments.
EP0620222A3 (en) Tetrahydro-beta-carbolines.
EP0641704A3 (en) Monowheel travois.
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
PH30784A (en) Encapsulated dosage forms.
EP0631512A4 (en) Medical valve.
GR3022484T3 (en) Osteosynthesis aid.
ZA927562B (en) Medicament.
EP0657163A4 (en) Antitussive.
ZA946728B (en) Tocopherois.
EP0620223A3 (en) Tetrahydro-pyrido-indole.
ZA941137B (en) Substitutet azolone derivatives.
EP0609763A3 (en) Ph-glasselectrode.
EP0657193A3 (en) Skibrake.
EP0646342A3 (en) Chair.
ZA947754B (en) Pharmaceutical combinations
ZA93694B (en) Pharmaceutical treatments.
EP0641898A3 (en) Manholecover.
GB9308802D0 (en) Treatment
EP0645218A3 (en) Toolshaft.
EP0643916A3 (en) Choux-mixes.
EP0635243A3 (en) Forceps.